Machine Learning-Informed Nano Co-Assembly Inhibits Fibroblast Activation Protein and Improves Drug Delivery in Fibrotic Tissue.

The improved bioavailability correlate with superior therapeutic outcomes in multiple disease models with progressive fibrosis. Overall, the authors establish SP as a versatile nanotherapeutic platform combining simplicity in preparation, mechanistic insights provided by XML, and broad applicability for diseases characterized by pathological fibrosis and impaired drug delivery.

Within the research, Countstar Rigel S2 assessed cell number and viability in the study's cell samples before single-cell analysis in the 2026 Advanced materials study.